You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Pharma & Healthcare

Global Topical Hemostatic Agents Industry Research Report, Growth Trends and Competitive Analysis 2021-2027

Topical hemostatic agents are important adjuncts to reduce blood loss after cardiac surgery and can have a role in reducing both “surgical” and “nonsurgical bleeding.” There are many topical hemostatic agents to choose from, and with several new products in this field being approved for use in the last few years,
The global Topical Hemostatic Agents market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
In terms of production side, this report researches the Topical Hemostatic Agents production capacity, value, ex-factory price, growth rate, market share by manufacturers, regions (or countries) and by Type.
In terms of consumption side, this report focuses on the consumption of Topical Hemostatic Agents by regions (countries) and by Application.
The global Topical Hemostatic Agents market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Topical Hemostatic Agents market. These figures have been provided in terms of both revenue and volume for the period 2016-2027. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise Topical Hemostatic Agents markets such as North America, Europe, China and Japan, etc. Key regions covered in the report are U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E
For the period 2016-2027, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Topical Hemostatic Agents market. For the period 2016-2021, it provides sales (consumption) analysis and forecast of different regional markets by each application as well as type segment in terms of volume.
Manufacturers
The report includes comprehensive company profiling of leading and emerging companies competing in the global Topical Hemostatic Agents market. It provides a detailed list of players operating at a global level. The players have been listed according to the type of products they offer in the global Topical Hemostatic Agents market and other factors. As part of the company profiling, the analysts authoring the report has provided the market entry year of each player considered for the research study. The report also offers extensive price, volume sales, and revenue analysis by the manufacturer at the global level for the period 2016-2021.
By Type and Application Segments
The report includes a detailed analysis of leading and type and application segments of the global Topical Hemostatic Agents market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue sales analysis and forecast of the global Topical Hemostatic Agents market by each type segment for the period 2016-2027. It also offers volume sales (consumption) analysis and forecast of the global Topical Hemostatic Agents market by each type segment for the same period. Also, it provides volume sales (consumption) analysis and forecast of the global Topical Hemostatic Agents market by each application segment for the same period.
This report includes the following manufacturers:
Ethicon
Pfizer
Baxter International
C. R. Bard
The Medicines Company
Anika Therapeutics
Advanced Medical Solutions
Integra LifeSciences
B Braun Melsungen
Gelita Medical
Equimedical
Vascular Solutions
Marine Polymer Technologies
Market Segment by Type
Gelation Sponge
Oxidized Regenerated Cellulose Based Hemostats
Others
Market Segment by Application
Hospitals
Surgical Centers
Nursing Homes
Research Methodology
To compile the detailed study of the global Topical Hemostatic Agents market, a robust research methodology has been adopted that aids in determining the key insights and also evaluates the growth prospects of the Topical Hemostatic Agents market. LBI Research analysts have conducted in-depth primary and secondary research to obtain crucial insights into the Topical Hemostatic Agents market. To carry out secondary research, the analysts have collected the information through company annual reports, journals, company press releases, and paid databases that were referred to gain and identify better opportunities in the global market.
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Topical Hemostatic Agents Market Size Growth Rate by Type
1.2.2 Gelation Sponge
1.2.3 Oxidized Regenerated Cellulose Based Hemostats
1.2.4 Others
1.3 Market Segment by Application
1.3.1 Global Topical Hemostatic Agents Market Share by Application (2016 VS 2021 VS 2027)
1.3.2 Hospitals
1.3.3 Surgical Centers
1.3.4 Nursing Homes
1.4 Study Objectives
1.5 Years Considered

2 Market Perspective
2.1 Global Topical Hemostatic Agents Market Size (2016-2027)
2.1.1 Global Topical Hemostatic Agents Revenue (2016-2027)
2.1.2 Global Topical Hemostatic Agents Sales (2016-2027)
2.2 Global Topical Hemostatic Agents Market Size across Key Geographies Worldwide: 2016 VS 2021 VS 2027
2.2.1 Global Topical Hemostatic Agents Sales by Regions (2016-2021)
2.2.2 Global Topical Hemostatic Agents Revenue by Regions (2016-2021)
2.3 Global Topical Hemostatic Agents Market Size Forecast by Region
2.3.1 Global Topical Hemostatic Agents Sales Forecast by Region (2022-2027)
2.3.2 Global Topical Hemostatic Agents Revenue Forecast by Region (2022-2027)
2.4 Global Top Topical Hemostatic Agents Regions (Countries) Ranking by Market Size
2.5 Topical Hemostatic Agents Industry Trends
2.5.1 Topical Hemostatic Agents Market Trends
2.5.2 Topical Hemostatic Agents Market Drivers
2.5.3 Topical Hemostatic Agents Market Challenges
2.5.4 Topical Hemostatic Agents Market Restraints

3 Competitive Landscape by Manufacturers
3.1 Global Top Topical Hemostatic Agents Manufacturers by Sales (2016-2021)
3.1.1 Global Topical Hemostatic Agents Sales by Manufacturers (2016-2021)
3.1.2 Global Topical Hemostatic Agents Sales Market Share by Manufacturers (2016-2021)
3.1.3 Global 5 and 10 Largest Manufacturers by Topical Hemostatic Agents Sales in 2020
3.2 Global Top Manufacturers Topical Hemostatic Agents by Revenue
3.2.1 Global Topical Hemostatic Agents Revenue by Manufacturers (2016-2021)
3.2.2 Top Topical Hemostatic Agents Manufacturers Covered: Ranking by Revenue
3.2.3 Global Topical Hemostatic Agents Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Topical Hemostatic Agents Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Topical Hemostatic Agents as of 2020)
3.4 Global Topical Hemostatic Agents Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Topical Hemostatic Agents Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Topical Hemostatic Agents Market
3.7 Key Manufacturers Topical Hemostatic Agents Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Global Topical Hemostatic Agents Market Size by Type
4.1 Global Topical Hemostatic Agents Historic Market Review by Type (2016-2021)
4.1.1 Global Topical Hemostatic Agents Sales Market Share by Type (2016-2021)
4.1.2 Global Topical Hemostatic Agents Revenue Market Share by Type (2016-2021)
4.1.3 Topical Hemostatic Agents Price by Type (2016-2021)
4.2 Global Topical Hemostatic Agents Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Topical Hemostatic Agents Sales Forecast by Type (2022-2027)
4.2.2 Global Topical Hemostatic Agents Revenue Forecast by Type (2022-2027)
4.2.3 Topical Hemostatic Agents Price Forecast by Type (2022-2027)

5 Global Topical Hemostatic Agents Market Size by Application
5.1 Global Topical Hemostatic Agents Historic Market Review by Application (2016-2021)
5.1.1 Global Topical Hemostatic Agents Sales Market Share by Application (2016-2021)
5.1.2 Global Topical Hemostatic Agents Revenue Market Share by Application (2016-2021)
5.1.3 Topical Hemostatic Agents Price by Application (2016-2021)
5.2 Global Topical Hemostatic Agents Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Topical Hemostatic Agents Sales Forecast by Application (2022-2027)
5.2.2 Global Topical Hemostatic Agents Revenue Forecast by Application (2022-2027)
5.2.3 Topical Hemostatic Agents Price Forecast by Application (2022-2027)

6 North America
6.1 North America Topical Hemostatic Agents Sales Breakdown by Company
6.1.1 North America Topical Hemostatic Agents Sales by Company (2016-2027)
6.1.2 North America Topical Hemostatic Agents Revenue by Company (2016-2027)
6.2 North America Topical Hemostatic Agents Market Size by Type (2016-2027)
6.2.1 North America Topical Hemostatic Agents Sales by Type (2016-2027)
6.2.2 North America Topical Hemostatic Agents Revenue by Type (2016-2027)
6.3 North America Topical Hemostatic Agents Market Size by Application (2016-2027)
6.3.1 North America Topical Hemostatic Agents Sales by Application (2016-2027)
6.3.2 North America Topical Hemostatic Agents Revenue by Application (2016-2027)
6.4 North America Topical Hemostatic Agents Market Size by Country
6.4.1 North America Topical Hemostatic Agents Sales by Country (2016-2027)
6.4.2 North America Topical Hemostatic Agents Revenue by Country (2016-2027)
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Topical Hemostatic Agents Sales Breakdown by Company
7.1.1 Europe Topical Hemostatic Agents Sales by Company (2016-2027)
7.1.2 Europe Topical Hemostatic Agents Revenue by Company (2016-2027)
7.2 Europe Topical Hemostatic Agents Market Size by Type (2016-2027)
7.2.1 Europe Topical Hemostatic Agents Sales by Type (2016-2027)
7.2.2 Europe Topical Hemostatic Agents Revenue by Type (2016-2027)
7.3 Europe Topical Hemostatic Agents Market Size by Application (2016-2027)
7.3.1 Europe Topical Hemostatic Agents Sales by Application (2016-2027)
7.3.2 Europe Topical Hemostatic Agents Revenue by Application (2016-2027)
7.4 Europe Topical Hemostatic Agents Market Size by Country
7.4.1 Europe Topical Hemostatic Agents Sales by Country (2016-2027)
7.4.2 Europe Topical Hemostatic Agents Revenue by Country (2016-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Topical Hemostatic Agents Sales Breakdown by Company
8.1.1 Asia Pacific Topical Hemostatic Agents Sales by Company (2016-2027)
8.1.2 Asia Pacific Topical Hemostatic Agents Revenue by Company (2016-2027)
8.2 Asia Pacific Topical Hemostatic Agents Market Size by Type (2016-2027)
8.2.1 Asia Pacific Topical Hemostatic Agents Sales by Type (2016-2027)
8.2.2 Asia Pacific Topical Hemostatic Agents Revenue by Type (2016-2027)
8.3 Asia Pacific Topical Hemostatic Agents Market Size by Application (2016-2027)
8.3.1 Asia Pacific Topical Hemostatic Agents Sales by Application (2016-2027)
8.3.2 Asia Pacific Topical Hemostatic Agents Revenue by Application (2016-2027)
8.4 Asia Pacific Topical Hemostatic Agents Market Size by Regions
8.4.1 Asia Pacific Topical Hemostatic Agents Sales by Regions
8.4.2 Asia Pacific Topical Hemostatic Agents Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Topical Hemostatic Agents Sales Breakdown by Company
9.1.1 Latin America Topical Hemostatic Agents Sales by Company (2016-2027)
9.1.2 Latin America Topical Hemostatic Agents Revenue by Company (2016-2027)
9.2 Latin America Topical Hemostatic Agents Market Size by Type (2016-2027)
9.2.1 Latin America Topical Hemostatic Agents Sales by Type (2016-2027)
9.2.2 Latin America Topical Hemostatic Agents Revenue by Type (2016-2027)
9.3 Latin America Topical Hemostatic Agents Market Size by Application (2016-2027)
9.3.1 Latin America Topical Hemostatic Agents Sales by Application (2016-2027)
9.3.2 Latin America Topical Hemostatic Agents Revenue by Application (2016-2027)
9.4 Latin America Topical Hemostatic Agents Market Size by Country
9.4.1 Latin America Topical Hemostatic Agents Sales by Country (2016-2027)
9.4.2 Latin America Topical Hemostatic Agents Revenue by Country (2016-2027)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Topical Hemostatic Agents Sales Breakdown by Company
10.1.1 Middle East and Africa Topical Hemostatic Agents Sales by Company (2016-2027)
10.1.2 Middle East and Africa Topical Hemostatic Agents Revenue by Company (2016-2027)
10.2 Middle East and Africa Topical Hemostatic Agents Market Size by Type (2016-2027)
10.2.1 Middle East and Africa Topical Hemostatic Agents Sales by Type (2016-2027)
10.2.2 Middle East and Africa Topical Hemostatic Agents Revenue by Type (2016-2027)
10.3 Middle East and Africa Topical Hemostatic Agents Market Size by Application (2016-2027)
10.3.1 Middle East and Africa Topical Hemostatic Agents Sales by Application (2016-2027)
10.3.2 Middle East and Africa Topical Hemostatic Agents Revenue by Application (2016-2027)
10.4 Middle East and Africa Topical Hemostatic Agents Market Size by Country
10.4.1 Middle East and Africa Topical Hemostatic Agents Sales by Country (2016-2027)
10.4.2 Middle East and Africa Topical Hemostatic Agents Revenue by Country (2016-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 U.A.E

11 Company Profiles
11.1 Ethicon
11.1.1 Ethicon Corporation Information
11.1.2 Ethicon Overview
11.1.3 Ethicon Topical Hemostatic Agents Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.1.4 Ethicon Topical Hemostatic Agents Products and Services
11.1.5 Ethicon Topical Hemostatic Agents SWOT Analysis
11.1.6 Ethicon Recent Developments
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Topical Hemostatic Agents Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.2.4 Pfizer Topical Hemostatic Agents Products and Services
11.2.5 Pfizer Topical Hemostatic Agents SWOT Analysis
11.2.6 Pfizer Recent Developments
11.3 Baxter International
11.3.1 Baxter International Corporation Information
11.3.2 Baxter International Overview
11.3.3 Baxter International Topical Hemostatic Agents Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.3.4 Baxter International Topical Hemostatic Agents Products and Services
11.3.5 Baxter International Topical Hemostatic Agents SWOT Analysis
11.3.6 Baxter International Recent Developments
11.4 C. R. Bard
11.4.1 C. R. Bard Corporation Information
11.4.2 C. R. Bard Overview
11.4.3 C. R. Bard Topical Hemostatic Agents Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.4.4 C. R. Bard Topical Hemostatic Agents Products and Services
11.4.5 C. R. Bard Topical Hemostatic Agents SWOT Analysis
11.4.6 C. R. Bard Recent Developments
11.5 The Medicines Company
11.5.1 The Medicines Company Corporation Information
11.5.2 The Medicines Company Overview
11.5.3 The Medicines Company Topical Hemostatic Agents Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.5.4 The Medicines Company Topical Hemostatic Agents Products and Services
11.5.5 The Medicines Company Topical Hemostatic Agents SWOT Analysis
11.5.6 The Medicines Company Recent Developments
11.6 Anika Therapeutics
11.6.1 Anika Therapeutics Corporation Information
11.6.2 Anika Therapeutics Overview
11.6.3 Anika Therapeutics Topical Hemostatic Agents Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.6.4 Anika Therapeutics Topical Hemostatic Agents Products and Services
11.6.5 Anika Therapeutics Topical Hemostatic Agents SWOT Analysis
11.6.6 Anika Therapeutics Recent Developments
11.7 Advanced Medical Solutions
11.7.1 Advanced Medical Solutions Corporation Information
11.7.2 Advanced Medical Solutions Overview
11.7.3 Advanced Medical Solutions Topical Hemostatic Agents Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.7.4 Advanced Medical Solutions Topical Hemostatic Agents Products and Services
11.7.5 Advanced Medical Solutions Topical Hemostatic Agents SWOT Analysis
11.7.6 Advanced Medical Solutions Recent Developments
11.8 Integra LifeSciences
11.8.1 Integra LifeSciences Corporation Information
11.8.2 Integra LifeSciences Overview
11.8.3 Integra LifeSciences Topical Hemostatic Agents Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.8.4 Integra LifeSciences Topical Hemostatic Agents Products and Services
11.8.5 Integra LifeSciences Topical Hemostatic Agents SWOT Analysis
11.8.6 Integra LifeSciences Recent Developments
11.9 B Braun Melsungen
11.9.1 B Braun Melsungen Corporation Information
11.9.2 B Braun Melsungen Overview
11.9.3 B Braun Melsungen Topical Hemostatic Agents Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.9.4 B Braun Melsungen Topical Hemostatic Agents Products and Services
11.9.5 B Braun Melsungen Topical Hemostatic Agents SWOT Analysis
11.9.6 B Braun Melsungen Recent Developments
11.10 Gelita Medical
11.10.1 Gelita Medical Corporation Information
11.10.2 Gelita Medical Overview
11.10.3 Gelita Medical Topical Hemostatic Agents Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.10.4 Gelita Medical Topical Hemostatic Agents Products and Services
11.10.5 Gelita Medical Topical Hemostatic Agents SWOT Analysis
11.10.6 Gelita Medical Recent Developments
11.11 Equimedical
11.11.1 Equimedical Corporation Information
11.11.2 Equimedical Overview
11.11.3 Equimedical Topical Hemostatic Agents Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.11.4 Equimedical Topical Hemostatic Agents Products and Services
11.11.5 Equimedical Recent Developments
11.12 Vascular Solutions
11.12.1 Vascular Solutions Corporation Information
11.12.2 Vascular Solutions Overview
11.12.3 Vascular Solutions Topical Hemostatic Agents Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.12.4 Vascular Solutions Topical Hemostatic Agents Products and Services
11.12.5 Vascular Solutions Recent Developments
11.13 Marine Polymer Technologies
11.13.1 Marine Polymer Technologies Corporation Information
11.13.2 Marine Polymer Technologies Overview
11.13.3 Marine Polymer Technologies Topical Hemostatic Agents Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.13.4 Marine Polymer Technologies Topical Hemostatic Agents Products and Services
11.13.5 Marine Polymer Technologies Recent Developments

12 Value Chain and Sales Channels Analysis
12.1 Topical Hemostatic Agents Value Chain Analysis
12.2 Topical Hemostatic Agents Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Topical Hemostatic Agents Production Mode & Process
12.4 Topical Hemostatic Agents Sales and Marketing
12.4.1 Topical Hemostatic Agents Sales Channels
12.4.2 Topical Hemostatic Agents Distributors
12.5 Topical Hemostatic Agents Customers
13 Research Findings and Conclusion

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
  • FORMAT: PDF
  • PUBLISHED DATE: Mar, 2021
  • NO OF PAGES: 101